Company Number: 15075160

Analysis Date: 2025-07-20 15:09 UTC

Financial Health Assessment Report for LP SD NINETY NINE LIMITED
(Period ending 31 August 2024)

---

1. Financial Health Score: C

Explanation:
The company shows a modest but positive net current asset position and positive shareholders’ funds, indicating basic financial viability. However, the margin of safety is very thin (net current assets of £6,696 against current liabilities of £116,531), signaling a fragile liquidity position. The company's very recent incorporation and small scale, combined with relatively high short-term liabilities compared to assets, suggest early-stage operational risks and limited financial cushion.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Assets	123,227	Good level of liquid and near-liquid assets
Cash	24,645	Healthy cash buffer but limited relative to liabilities
Debtors	78,582	Significant receivables; cash conversion critical
Current Liabilities	116,531	High short-term obligations
Net Current Assets	6,696	Positive but narrow working capital margin
Fixed Assets	432	Minimal capital investment; asset-light model
Shareholders’ Funds	7,128	Positive equity base; small scale
Number of Employees	Approx. 3	Small workforce consistent with micro/small scale

Interpretation:

• The company has a positive net working capital, meaning current assets exceed current liabilities, but only marginally. This is a key "vital sign" akin to a pulse that is present but weak.
• Cash on hand is reasonable but needs to be monitored closely given liabilities due within one year.
• Debtors are significant, which means the company is somewhat dependent on collecting payments in a timely manner to sustain operations.
• Minimal fixed assets suggest a business model relying more on trading or services rather than heavy investment.

---

3. Diagnosis

LP SD NINETY NINE LIMITED is in the early stages of its business lifecycle, having been incorporated in August 2023 and filing its first set of accounts for the 12.5-month period ending August 2024. The company operates in a specialized retail sector (dispensing chemist in specialized stores), which can face regulatory and operational challenges.

• Liquidity Status: The narrow positive net current assets indicate a fragile liquidity "heartbeat." The company must maintain efficient cash flow management to avoid a "cash flow crisis," as current liabilities are high relative to liquid assets.
• Capital Structure: Equity base is positive but very small, typical for a newly formed private limited company. No evidence of debt financing beyond short-term trade and related party payables.
• Operational Health: The presence of trade creditors and related party loans suggests reliance on suppliers and group support. The related party loan is interest-free and repayable on demand, a useful buffer but also a potential risk if called in unexpectedly.
• Governance: Directors appointed recently with no adverse records; control held predominantly by a related corporate entity (SM Pharmco Limited), indicating a group structure that may provide operational support.
• Profitability: No profit & loss statement filed (exempt for small companies), so profitability cannot be assessed directly. Retained earnings are positive, indicating some level of profitability or capital injection.

Summary Diagnosis: The company exhibits symptoms of a "young patient" with a fragile but stable financial condition. There is no immediate "financial distress," but the company is vulnerable to shocks and needs vigilant cash management.

---

4. Recommendations

1. Strengthen Liquidity:

   • Improve cash flow by accelerating debtor collections and negotiating extended payment terms with creditors.
   • Consider maintaining a larger cash buffer to absorb unexpected expenses or delays in receivables.

2. Monitor Related Party Transactions:

   • Regularly review the terms and timing of related party loans for any changes that could impact liquidity.
   • Maintain transparent documentation to ensure these do not create hidden financial stress.

3. Build Financial Resilience:

   • Plan for incremental capital injections or retained earnings to increase shareholders’ funds and reduce financial vulnerability.
   • Evaluate opportunities for cost control and operational efficiencies given the small employee base.

4. Prepare for Growth and Compliance:

   • As the company grows, ensure timely filing of accounts and returns to avoid penalties and maintain good standing.
   • Consider engaging financial advisory support to build more detailed budgeting and forecasting models.

---